109 related articles for article (PubMed ID: 1794415)
1. Ridogrel prevents the thromboxane-mediated pressor response and oedema induced by hydrogen peroxide in isolated rabbit lungs.
Corten I; Peeters FA; Rampart M; Bult H; Buyssens N; Herman AG
Eur J Pharmacol; 1991 Aug; 201(1):83-90. PubMed ID: 1794415
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
3. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
Quest DW; Wilson TW
Jpn J Pharmacol; 1998 Dec; 78(4):479-86. PubMed ID: 9920205
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
[TBL] [Abstract][Full Text] [Related]
5. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F
Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169
[TBL] [Abstract][Full Text] [Related]
6. C3a57-77, a C-terminal peptide, causes thromboxane-dependent pulmonary vascular constriction in isolated perfused rat lungs.
Morganroth ML; Schoeneich SO; Till GO; Ward PA; Horvath SJ; Glovsky MM
Am Rev Respir Dis; 1990 Feb; 141(2):296-300. PubMed ID: 2105683
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.
De Clerck F; Loots W; Somers Y; Beetens J; Wouters L; Wynants J; Janssen PA
Br J Pharmacol; 1990 Apr; 99(4):631-6. PubMed ID: 2113823
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury.
Ljungman AG; Grum CM; Deeb GM; Bolling SF; Morganroth ML
Am Rev Respir Dis; 1991 Mar; 143(3):610-7. PubMed ID: 1900402
[TBL] [Abstract][Full Text] [Related]
9. Effect of ridogrel on vascular contractions caused by vasoactive substances released during platelet activation.
Janssens WJ; Cools FJ; Hoskens LA; Van Nueten JM
Thromb Haemost; 1990 Aug; 64(1):91-6. PubMed ID: 2148850
[TBL] [Abstract][Full Text] [Related]
10. Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists.
Pakala R; Benedict CR
J Lab Clin Med; 1998 Jun; 131(6):527-37. PubMed ID: 9626988
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury.
Zamora CA; Baron DA; Heffner JE
J Appl Physiol (1985); 1993 Jan; 74(1):224-9. PubMed ID: 8444695
[TBL] [Abstract][Full Text] [Related]
12. Ridogrel: a selective inhibitor of the cytochrome P450-dependent thromboxane synthesis.
Vanden Bossche H; Willemsens G; Bellens D; Janssen PA
Biochem Pharmacol; 1992 Feb; 43(4):739-44. PubMed ID: 1540227
[TBL] [Abstract][Full Text] [Related]
13. Involvement of thromboxane in injury to isolated rat lungs perfused with phorbol myristate acetate in the presence and absence of neutrophils.
Carpenter LJ; Roth RA
Toxicol Appl Pharmacol; 1987 Oct; 91(1):33-45. PubMed ID: 3672516
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 receptor antagonism and synthase inhibition in essential hypertension.
Ritter JM; Barrow SE; Doktor HS; Stratton PD; Edwards JS; Henry JA; Gould S
Hypertension; 1993 Aug; 22(2):197-203. PubMed ID: 8340155
[TBL] [Abstract][Full Text] [Related]
15. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep.
Kubo K; Kobayashi T
Am Rev Respir Dis; 1985 Sep; 132(3):494-9. PubMed ID: 3898941
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 releases endothelium-derived endoperoxides and thromboxane A2 in porcine coronary arteries with regenerated endothelium.
Park SJ; Lee JJ; Vanhoutte PM
Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):872-8. PubMed ID: 11270983
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase inhibitor prevents pulmonary edema in response to H2O2.
Johnson A; Phillips P; Hocking D; Tsan MF; Ferro T
Am J Physiol; 1989 Apr; 256(4 Pt 2):H1012-22. PubMed ID: 2705544
[TBL] [Abstract][Full Text] [Related]
18. Placental transfer of the thromboxane synthetase inhibitor ridogrel in the late-pregnant ewe.
Schneider TJ; Struijk PC; Wallenburg HC
Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):83-7. PubMed ID: 10471147
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin biosynthesis and reduced 5-HT uptake after complement-induced endothelial injury in the dog isolated lung.
Bult H; Heiremans JJ; Herman AG; Malcorps CM; Peeters FA
Br J Pharmacol; 1988 Apr; 93(4):791-802. PubMed ID: 3291998
[TBL] [Abstract][Full Text] [Related]
20. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
de Chaffoy de Courcelles D; De Clerck F
Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
